A radiomic approach to predict outcome in patients treated with SBRT for early stage NSCLC

被引：0
|
作者：
Cozzi, L. [1 ]
Davide, F. [1 ]
Fiorenza, D. R. [1 ]
Pierina, N. [2 ]
Antonella, F. [1 ]
Ciro, F. [1 ]
Donato, P. [1 ]
Stefano, T. [1 ]
Giacomo, R. [1 ]
Marta, S. [1 ]
机构：
[1] Humanitas, Radiotherapy, Rozzano, Italy
[2] Humanitas, Radiotherapyt, Rozzano, Italy
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1567
引用
收藏
页码：S848 / S849
页数：2
相关论文
共 50 条
  • [21] Radiomic approach for prediction of response to radiochemotherapy in stage III NSCLC
    Ramella, S.
    Miele, M.
    Silipigni, S.
    Gentile, S.
    Iannello, G.
    Cordelli, E.
    Soda, P.
    Fiore, M.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S968 - S969
  • [22] CLINICAL TOXICITY AND EARLY OUTCOME DATA OF PATIENTS WITH EARLY STAGE NSCLC TREATED WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) AT GUY'S & ST THOMAS' HOSPITAL NHS FOUNDATION TRUST, UK
    Qureshi, Asad
    Hughes, Simon
    Landau, David
    Gajjar, Bhakti
    Ahmad, Shahreen
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S824 - S825
  • [23] VMAT based SBRT in early stage NSCLC: Outcomes and toxicities
    Martin Garcia, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S732 - S733
  • [24] OUTCOME AFTER SBRT FOR POTENTIALLY OPERABLE NSCLC PATIENTS
    Rossi, M.
    Peulen, H.
    van Tinteren, H.
    Wouters, M.
    Sonke, J. -J.
    Baas, P.
    Smit, E. F.
    Belderbos, J.
    ANNALS OF ONCOLOGY, 2015, 26
  • [25] Integrating Radiomics and Circulating Tumor Cell Analysis Improves Prediction of Treatment Outcomes of Early Stage NSCLC Patients Treated with SBRT
    Jiao, Z.
    Li, H.
    Xiao, Y.
    Feigenberg, S. J.
    Kao, G. D.
    Fan, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S117 - S117
  • [26] Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab
    Dohan, Anthony
    Gallix, Benoit
    Guiu, Boris
    Le Malicot, Karine
    Reinhold, Caroline
    Soyer, Philippe
    Bennouna, Jaafar
    Ghiringhelli, Francois
    Barbier, Emilie
    Boige, Valerie
    Taieb, Julien
    Bouche, Olivier
    Francois, Eric
    Phelip, Jean-Marc
    Borel, Christian
    Faroux, Roger
    Seitz, Jean-Francois
    Jacquot, Stephane
    Ben Abdelghani, Meher
    Khemissa-Akouz, Faiza
    Genet, Dominique
    Jouve, Jean Louis
    Rinaldi, Yves
    Desseigne, Francoise
    Texereau, Patrick
    Suc, Etienne
    Lepage, Come
    Aparicio, Thomas
    Hoeffel, Christine
    GUT, 2020, 69 (03) : 531 - 539
  • [27] Should All Medically Inoperable Patients with Early-Stage NSCLC Need SBRT Treatment?
    Biswas, T.
    Vempati, P.
    Efird, J. T.
    Zheng, Y.
    Podder, T. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E6 - E6
  • [28] Incidental Mediastinal Dose Does Not Explain Low Mediastinal Nodal Recurrence Rates in Early-Stage NSCLC Patients Treated With SBRT
    Rwigema, J.
    Wang, P.
    Lee, J.
    Garon, E.
    Lee, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S35 - S35
  • [29] Is There Any Prognostic Significance of the Level of Change in SUVmax after SBRT in Patients with Early Stage NSCLC?
    Yaprak, Gokhan
    Ozen, Alaattin
    Tugrul, Fuzuli
    Ozugur, Sule
    Isik, Naciye
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2019, 29 (03): : 130 - 138
  • [30] Is there any prognostic significance of the level of change in SUVmax after SBRT in patients with early stage NSCLC?
    Yaprak, G.
    Ozen, A.
    Tugrul, F.
    Ozugur, S.
    Isik, N.
    ANNALS OF ONCOLOGY, 2019, 30 : 28 - 28
12345